Skip to main content
. 2024 Apr 4;44(9):1001–1013. doi: 10.1093/asj/sjae073

Figure 4.

Figure 4.

Photographic outcomes for 3 patients before and after treatment with HAEYE. Images A-C show a White, 54-year-old, postmenopausal female treated with 2.0 mL HAEYE with a needle (1.0 mL on each side). (A) Before treatment, blinded evaluator GIHS score 3 (severe, both sides); (B) at Month 3, GIHS score 1 (mild, both sides); (C) at Month 12 before retreatment, GIHS score 0 (none, right) and 1 (mild, left). Images D-F show a White, 51-year-old male treated with 4.0 mL HAEYE (2.0 mL on each side) by cannula injection. (D) Before treatment, blinded evaluator GIHS score 3 (severe, both sides); (E) at Month 3, GIHS score 1 (mild, both sides); (F) at Month 12 before retreatment, GIHS scores 2 (moderate, right), 3 (severe, left). Images G-I show a White, 26-year-old female treated with 1.8 mL HAEYE (0.8 mL on right side and 1.0 mL on left side) by needle injection. (G) Before treatment, blinded evaluator GIHS score 2 (moderate, both sides); (H) at Month 3, GIHS score 0 (none, both sides); (I) at Month 12 before retreatment, GIHS score 1 (mild, both sides). GIHS, Galderma infraorbital hollow scale.